CNR1 Antikörper (AA 150-200)
Kurzübersicht für CNR1 Antikörper (AA 150-200) (ABIN5540252)
Target
Alle CNR1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 150-200
-
Spezifität
- This antibody detects endogenous levels of Cannabinoid receptor 1 (region surrounding Phe189).
-
Aufreinigung
- Affinity Chromatography
-
Immunogen
- Synthetic peptide corresponding to amino acids 150-200 of Human CB1.
-
-
-
-
Applikationshinweise
- Western blot : 1/500-1/1000. Immunohistochemistry on Paraffin sections : 1/50-1/200.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- 95 % by SDS-PAGE) Aff - Purified
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer. Avoid repeated freezing and thawing. Shelf life: one year from despatch.
-
Haltbarkeit
- 12 months
-
-
- CNR1 (Cannabinoid Receptor 1 (CNR1))
-
Andere Bezeichnung
- cannabinoid receptor 1
-
Hintergrund
- The cannabinoid receptors (CB1 and CB2) are G protein-coupled receptors that inhibit adenylate cyclase activity in response to psychoactive cannabinoids. CB1 is expressed in brain tissue and, in low levels, in testis. CB2 is expressed only by cells of the immune system. The cannabinoid receptors mediate most of the cannabinoid-induced responses in a dose-dependent, stereoselective manner. This response system is thought to be involved in specific brain functions, such as nociception, control of movement, memory and neuroendocrine regulation, as well as having a possible role in brain development. In addition, CB1 may mediate the addictive behavior involved with the use of psychoactive cannabinoids, such as THC in marijuana.
-
UniProt
- P21554
-
Pathways
- Feeding Behaviour
Target
-